LINCOLN
Lincoln Pharmaceuticals Share Price
₹673.55 +14.25 (2.16%)
05 Nov, 2024 17:34
Start SIP in LINCOLN
Start SIPPerformance
- Low
- ₹655
- High
- ₹677
- 52 Week Low
- ₹535
- 52 Week High
- ₹812
- Open Price₹661
- Previous Close₹659
- Volume18,385
Investment Returns
- Over 1 Month + 1.59%
- Over 3 Month + 2.61%
- Over 6 Month + 12.67%
- Over 1 Year + 22.24%
Smart Investing Starts Here Start SIP with Lincoln Pharmaceuticals for Steady Growth!
Lincoln Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 13.8
- PEG Ratio
- 0.5
- Market Cap Cr
- 1,349
- P/B Ratio
- 2.3
- Average True Range
- 22.68
- EPS
- 46.1
- Dividend Yield
- 0.3
- MACD Signal
- -9.68
- RSI
- 43.26
- MFI
- 37.88
Lincoln Pharmaceuticals Financial
Indicator | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 |
---|---|---|---|---|---|
Net Sales/Income from operations | 147.28 | 142.49 | 146.45 | 155.99 | 135.62 |
Total Income From Operations | 147.28 | 142.49 | 146.45 | 155.99 | 135.62 |
P/L Before Interest, Excpt. Items & Tax | 29.92 | 22.72 | 37.87 | 37.26 | 25.86 |
P/L Before Exceptional Items & Tax | 29.48 | 22.22 | 37.71 | 36.87 | 25.45 |
P/L After Tax from Ordinary Activities | 23.67 | 18.60 | 28.04 | 27.65 | 19.01 |
Net Profit/Loss For the Period | 23.67 | 18.60 | 28.04 | 27.65 | 19.01 |
Lincoln Pharmaceuticals Technicals
EMA & SMA
Current Price
₹673.55
+
14.25
(2.16%)
- Bullish Moving Average 11
- Bearish Moving Average 5
- 20 Day
- ₹671.41
- 50 Day
- ₹680.07
- 100 Day
- ₹670.34
- 200 Day
- ₹639.63
Resistance and Support
662.43
- R3 705.87
- R2 692.43
- R1 675.87
- S1 645.87
- S2 632.43
- S3 615.87
Lincoln Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-08-08 | Quarterly Results | |
2024-05-16 | Audited Results & Final Dividend | |
2024-02-08 | Quarterly Results | |
2023-11-02 | Quarterly Results | |
2023-08-10 | Quarterly Results |
Lincoln Pharmaceuticals F&O
- NSE Symbol
- LINCOLN
- BSE Symbol
- 531633
- Managing Director
- Mr. Mahendra G Patel
- ISIN
- INE405C01035
Lincoln Pharmaceuticals FAQs
Lincoln Pharmaceuticals share price is ₹673 As on 05 November, 2024 | 17:20
The Market Cap of Lincoln Pharmaceuticals is ₹1349.1 Cr As on 05 November, 2024 | 17:20
The P/E ratio of Lincoln Pharmaceuticals is 13.8 As on 05 November, 2024 | 17:20
The PB ratio of Lincoln Pharmaceuticals is 2.3 As on 05 November, 2024 | 17:20